Takeda Pharmaceuticals

Teresa Bitetti is President of the Global Oncology Business Unit. She is responsible for oncology business activities in ten countries, including the U.S., Japan, U.K., Ireland, Germany, France, Italy, Spain, Portugal, and Canada.

Before joining Takeda, Teresa Bitetti was the Senior Vice President, Head of Worldwide Oncology Commercialization at Bristol-Myers Squibb. In this role, Teresa significantly enhanced the long-term strategic direction of the immuno-oncology portfolio. In addition, she further enhanced the model of collaboration with the R&D team to ensure the long-term success of its marketed and pipeline Oncology products. In the company, some of her key leadership roles have included Senior Vice President and Head of U.S. Oncology, President and GM of BMS Canada, and Worldwide Head of the BMS Virology business.

Prior to joining Bristol-Myers Squibb, Teresa held various roles of increasing responsibility at Mobil Oil Corporation, where she was part of the Capital Markets Group and was responsible for the investment of Mobil's worldwide pension assets.

Over Teresa’s 20+ year career, she has been highly recognized for her adept ability to mobilize teams to deliver exceptional performance. Her notable awards include Medical Marketing Association 2003 Pharmaceutical Marketer of the Year Award and Medical Marketing & Media 2016 Hall of Femme Honoree.

Teresa holds a BA in Classical Civilization from Wellesley College and an MBA in Finance from Darden School of Business at University of Virginia.